Briefly

Senetek, a British biotechnology company, settled U.S. securities regulators’ allegations that the company violated fair-disclosure rules by giving nonpublic information about revenue and earnings to two research firms. Senetek, which has U.S.-listed shares and headquarters in Napa, Calif., disclosed the financial information in December 2001 and March 2002 to two research analysts, according to the Securities and Exchange Commission. The company didn’t admit to or deny the SEC’s allegations. The agency did not levy a fine.